Lysine 2-hydroxyisobutyrylation of HXK1 alters energy metabolism and KATP channel function in the atrium from patients with atrial fibrillation

Background: Atrial fibrillation (AF) is the most common form of arrhythmia and is a growing clinical problem. Post-translational modifications (PTMs) constitute crucial epigenetic mechanisms but modification of lysine 2-hydroxyisobutyrylation (K_hib) in AF is still unknown. This study aimed to investigate the role and mechanism of K_hib in AF.

Methods: PTM proteomics was applied in the human atrial tissue from AF and sinus rhythm patients with heart valve disease during cardiac surgery to identify the K_hib sites. The functional changes of differential modification sites were further validated at the cellular level. Cellular electrophysiology was performed to record the ion channel current and action potential duration (APD).

Results: The modification of 124 K_hib sites in 35 proteins and 67 sites in 48 proteins exhibited significant increase or decrease in AF compared to sinus rhythm. Ten K_hib sites were included in energy metabolism-related signaling pathways (HXK1, TPIS, PGM1, and OPDX in glycolysis; MDHC and IDH3A in tricarboxylic acid circle; NDUS2, ETFB, ADT3, and ATPB in oxidative respiratory chain). Importantly, decreased HXK1 K418_hib regulated by HDAC2 attenuated the original chemical binding domain between HXK1 and glucose, inhibited the binding ability between HXK1 and glucose, and reduced catalytic ability of the enzyme, resulting in low production of glucose-6-phosphate and ATP. Further, it also increased Kir6.2 protein and the current of K_ATP channel, and decreased APD.

Conclusions: This study demonstrates the importance of K_hib to catalysis of HXK1 and reveals molecular mechanisms of HXK1 K418_hib in AF, providing new insight into strategies of AF.  

Dr. Guo-Wei He Current research focused on genomics, transcriptomics, proteomics, and metabolomics in cardiovascular diseases. Performed more than 7,000 open heart operations. Obtained more than 80 research grants. “He Classification” and “He solutions” for CABG grafts. First Class Award, Tianjin Municipal Natural Science Award, 2012. First Class Award, Prize of Science & Technology, The China Medicine Education Association, 2021. Published 409 articles/reports in SCI (E)-index international journals. Ranked in World's Top 2% Scientists (1999, 2020, 2021, 2022) Google scholar citation = 10,654: H-index: 55: i10 Index: 200.